Park Yong-Man, Lee Donghyoun, Jo Jaemin, Chang Won-Bae
Department of Surgery, Samsung Medical Center, Seoul, Korea.
Department of Surgery, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.
Ann Surg Treat Res. 2025 Jun;108(6):362-366. doi: 10.4174/astr.2025.108.6.362. Epub 2025 Jun 2.
Chemo-port insertion is performed by a radiologist or surgeon in an interventional radiology (IR) suite or an operating room (OR). The complication rate is approximately 3%-4%. However, there is still a lack of data for comparison when it is performed in different conditions such as IR suite and OR.
This study is for the safety of adult cancer patients after chemo-port implantation by comparing postoperative complication types and rates in different places. Among 375 patients who underwent chemo-port implantation, 203 patients underwent chemo-port implantation by radiologists in an IR suite, and 172 patients underwent the procedure by general surgeons in an OR. In both groups, early and late mortality were investigated. Early and late complication types and rates were also compared, and our study results were compared to the literature.
Patients' characteristics showed no differences. Mortality after the procedure was 39 in OR 72 in IR (P < 0.01). Early mortality at 7 days was 1 in IR, no patient in OR (P = 0.36). Catheter problems did not show a statistical difference in these 2 groups (1.16% 0.49%, P = 0.47). Venous thrombosis happened in 4 and 7 (2.33% 3.45%, P = 0.13), and the central line bloodstream infection was in 5 patients and 6 patients (2.91% . 2.96%, P = 0.98), respectively. Skin problems were 6 and 7 (3.49% 3.45%, P = 0.98). Port site infection happened in 6 patients in each group (3.49% 2.96%, P = 0.77).
Chemo-port implantation can be performed in OR or IR without difference in complication rates.
化疗端口植入术由放射科医生或外科医生在介入放射学（IR）套房或手术室（OR）中进行。并发症发生率约为3%-4%。然而，在诸如IR套房和手术室等不同条件下进行该手术时，仍缺乏用于比较的数据。
本研究旨在通过比较不同地点术后并发症的类型和发生率，探讨成年癌症患者化疗端口植入后的安全性。在375例行化疗端口植入术的患者中，203例由放射科医生在IR套房进行，172例由普通外科医生在手术室进行。对两组患者的早期和晚期死亡率进行调查。同时比较早期和晚期并发症的类型和发生率，并将我们的研究结果与文献进行比较。
患者特征无差异。术后死亡率在手术室组为39例，在IR套房组为72例（P<0.01）。术后7天的早期死亡率在IR套房组为1例，手术室组无患者死亡（P=0.36）。两组导管问题无统计学差异（1.16%对0.49%，P=0.47）。静脉血栓形成分别发生4例和7例（2.33%对3.45%，P=0.13），中心静脉导管相关血流感染分别发生5例和6例（2.91%对2.96%，P=0.98）。皮肤问题分别发生6例和7例（3.49%对3.45%，P=0.98）。两组端口部位感染均发生6例（3.49%对2.96%，P=0.77）。
化疗端口植入术在手术室或IR套房进行，并发症发生率无差异。
